PubRank

J H Kocsis

Author PubWeight™ 54.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 1998 4.48
2 Relationship of lithium chloride dose to treatment response in acute mania. Arch Gen Psychiatry 1976 1.81
3 A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996 1.71
4 Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 1999 1.60
5 Individual psychotherapies for depressed HIV-positive patients. Am J Psychiatry 1995 1.57
6 Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. Am J Psychiatry 2000 1.52
7 Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry 1997 1.44
8 Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry 1998 1.42
9 Results of the DSM-IV mood disorders field trial. Am J Psychiatry 1995 1.33
10 A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 1999 1.33
11 Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 2000 1.33
12 A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996 1.31
13 The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry 1998 1.05
14 Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord 1992 1.02
15 Psychiatric comorbidity in methadone maintained patients. J Addict Dis 1998 0.99
16 Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 1985 0.94
17 Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord 2001 0.92
18 A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999 0.92
19 Association of recurrent suicidal ideation with nonremission from acute mixed mania. Am J Psychiatry 1998 0.91
20 Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry 1985 0.91
21 The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry 1998 0.90
22 A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor. Arch Gen Psychiatry 1989 0.90
23 Cost effectiveness of screening for clinical trials by research assistants versus senior investigators. J Psychiatr Res 1999 0.89
24 Correlates of suicidal ideation in dysphoric mania. J Affect Disord 1999 0.87
25 Desipramine treatment of alcoholism. Psychopharmacol Bull 1991 0.86
26 Age as a predictor of treatment response in endogenous depression. J Clin Psychopharmacol 1983 0.86
27 Symptomatology in dysthymic and major depressive disorder. Psychiatr Clin North Am 1996 0.86
28 Predictors of response to desipramine in dysthymia. J Clin Psychopharmacol 1995 0.84
29 Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients. Acta Psychiatr Scand 1987 0.84
30 Psychotic vs. nonpsychotic depression: comparison of treatment response. J Nerv Ment Dis 1982 0.84
31 Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull 1995 0.84
32 Pharmacotherapy for chronic depression. Psychiatr Clin North Am 1996 0.83
33 Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res 1988 0.82
34 Depressive behavior and hyperactive adrenocortical function. Am J Psychiatry 1985 0.81
35 Psychotic depression: a separate entity? Am J Psychiatry 1981 0.80
36 Imipramine for treatment of chronic depression. Psychopharmacol Bull 1985 0.80
37 Social-vocational adjustment in unipolar mood disorders: results of the DSM-IV field trial. J Affect Disord 1996 0.80
38 Sexual dysfunction secondary to depressive disorders. J Gend Specif Med 2001 0.80
39 Standardized assessment of dysthymia: report of a National Institute of Mental Health conference. Psychopharmacol Bull 1997 0.79
40 Sudden death and antipsychotic drugs. Hosp Community Psychiatry 1984 0.79
41 Lithium ratio and maintenance treatment response. J Affect Disord 1982 0.78
42 The effect of psychobiological research on treatment outcome. A controlled study. Arch Gen Psychiatry 1981 0.77
43 Acute response of social functioning in dysthymic patients with desipramine. J Affect Disord 1995 0.77
44 Dexamethasone suppression in major depression. Biol Psychiatry 1984 0.77
45 Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med 1982 0.76
46 Imipramine and amitriptyline plasma concentrations and clinical response in major depression. Br J Psychiatry 1986 0.76
47 Blunted beta-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Isoproterenol dose-response studies. Arch Gen Psychiatry 1988 0.76
48 Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients. J Clin Psychiatry 1998 0.76
49 Normalization of blunted lymphocyte beta-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy. Arch Gen Psychiatry 1990 0.75
50 Desipramine in the treatment of depressed alcoholics. Am J Psychiatry 1994 0.75
51 Increase in CSF protein in association with ECT. J Neurol Neurosurg Psychiatry 1978 0.75
52 Thyroid function in patients maintained on lithium. Psychiatry Res 1988 0.75
53 Low-dose lithium augmentation of divalproex in geriatric mania. J Clin Psychiatry 2000 0.75
54 Methylphenidate and SSRI-Induced sexual side effects. J Clin Psychiatry 1996 0.75
55 Interpersonal improvement in chronically depressed patients treated with desipramine. J Affect Disord 1996 0.75
56 Neuroendocrine studies in depression. Relationship to suicidal behavior. Ann N Y Acad Sci 1986 0.75
57 Desipramine for the treatment of "pure" dysthymia versus "double" depression. Am J Psychiatry 1994 0.75
58 Six months of desipramine for dysthymia: can dysthymic patients achieve normal social functioning? J Affect Disord 1999 0.75
59 Maintenance desipramine for dysthymia: a placebo-controlled study. J Affect Disord 2001 0.75
60 Studies of amine metabolites in depressed patients. Relationship to suicidal behavior. Ann N Y Acad Sci 1986 0.75
61 Treatment of mania. Compr Psychiatry 1982 0.75
62 Chronic depression: demographic and clinical characteristics. Psychopharmacol Bull 1986 0.75
63 Amoxapine versus amitriptyline for continuation therapy of depression. J Clin Psychopharmacol 1990 0.75
64 Retreatment for relapse following desipramine discontinuation in dysthymia. Am J Psychiatry 1995 0.75
65 Cerebrospinal fluid levels of amitriptyline, nortriptyline, imipramine and desmethylimipramine. Relationship to plasma levels and treatment outcome. J Affect Disord 1985 0.75
66 Attenuation of response to serotonin reuptake inhibitors. Am J Psychiatry 1995 0.75
67 A controlled study of satisfaction among psychobiology research patients. Am J Psychiatry 1982 0.75
68 Drug treatment in depression. Hosp Community Psychiatry 1992 0.75
69 Delusional depression and inappropriate antidiuretic hormone secretion. Biol Psychiatry 1983 0.75
70 Dexamethasone suppression test in geriatric depression. Biol Psychiatry 1984 0.75
71 Interepisode consistency of dexamethasone suppression test results in affective disorders. Am J Psychiatry 1986 0.75
72 Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives. J Clin Psychopharmacol 1984 0.75
73 Suicide and adrenocortical function. Psychopharmacol Bull 1986 0.75
74 Nocturnal serum melatonin in major depressive disorder before and after desmethylimipramine treatment. Psychopharmacol Bull 1985 0.75
75 Induction of mania. Arch Gen Psychiatry 1983 0.75
76 High-dose lithium therapy. Biol Psychiatry 1978 0.75
77 Qualitative differences in manic symptoms during mixed versus pure mania. Compr Psychiatry 2000 0.75
78 Lithium maintenance: factors affecting outcome. Am J Psychiatry 1979 0.75